Bio Farmag is working to develop a world-first innovative test for the detection of breast cancer using hair. The breakthrough technology that underpins the Bio Farmag™ Test is the discovery by an Australian scientist that breast cancer can potentially be detected by synchrotron x-ray diffraction of hair. The test is non-invasive and suitable for women from as early as 20 years of age. It may provide early detection of breast cancer thus assist in early treatment. Early detection benefits range from increased survival, increased treatment options and improved quality of life. The Bio Farmag™ Test is in trial and not yet available commercially.
An updated formal presentation of key corporate information about Bio Farmag.
Click here to download
Bio Farmag Holdings Limited ACN 000 689 725 Constitution approved at the General Meeting on 12 January 2007.
Click here to download
